To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Canadian Agency for Drugs and Technologies in Health
The Canadian Agency for Drugs and Technologies in Health (CADTH) is a national body that "provides Canada’s federal, provincial and territorial health care decision makers with credible, impartial advice and evidence-based information about the effectiveness and efficiency of drugs and other health technologies". Before April 2006, CADTH was known as the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). 
Additional recommended knowledge
CADTH is the home of Canada's Health Technology Assessment (HTA), the Common Drug Review (CDR), and the Canadian Optimal Medication Prescribing and Utilization Service (COMPUS). The programs of CADTH are funded by the provincial and territorial Ministries of Health (with the exception of Quebec) and by Health Canada.
The main offices of CADTH are located in Ottawa, Ontario. There is also an office in Edmonton, Alberta, and individual Liaison Officers are located in most provinces.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Canadian_Agency_for_Drugs_and_Technologies_in_Health". A list of authors is available in Wikipedia.|